These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36683826)

  • 1. Comparative Analysis of Two Enoxaparin Sodium Drugs by Heptest.
    Berkovskii AL; Sergeeva EV; Chernobrovkin MG; Zinchenko AV
    Pharm Chem J; 2023; 56(10):1407-1410. PubMed ID: 36683826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring therapy with LMW heparin: a comparison of three chromogenic substrate assays and the Heptest clotting assay.
    Abildgaard U; Norrheim L; Larsen AE; Nesvold A; Sandset PM; Odegaard OR
    Haemostasis; 1990; 20(4):193-203. PubMed ID: 2173672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of low-molecular-weight heparin (enoxaparin sodium) and standard unfractionated heparin for haemodialysis anticoagulation.
    Saltissi D; Morgan C; Westhuyzen J; Healy H
    Nephrol Dial Transplant; 1999 Nov; 14(11):2698-703. PubMed ID: 10534515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory monitoring of a low molecular weight heparin (enoxaparin) with a new clotting test (Heptest).
    Bara L; Combe-Tamzali S; Conard J; Horellou MH; Samama M
    Haemostasis; 1987; 17(3):127-33. PubMed ID: 3609913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tissue factor pathway inhibitor (TFPI) in the HEPTEST assay and in an amidolytic anti factor Xa assay for LMW heparin.
    Kristensen HI; Ostergaard PB; Nordfang O; Abildgaard U; Lindahl AK
    Thromb Haemost; 1992 Sep; 68(3):310-4. PubMed ID: 1332210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of persistent anti-Xa activity following administration of the low molecular weight heparin enoxaparin sodium (Clexane).
    Brieger D; Dawes J
    Thromb Haemost; 1994 Aug; 72(2):275-80. PubMed ID: 7831665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study on a new one-stage clotting assay for heparin and its low molecular weight derivatives.
    Harenberg J; Giese C; Knödler A; Zimmermann R
    Haemostasis; 1989; 19(1):13-20. PubMed ID: 2537786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence of a biosimilar enoxaparin sodium to Clexane
    Martínez González J; Monreal M; Ayani Almagia I; Llaudó Garín J; Ochoa Díaz de Monasterioguren L; Gutierro Adúriz I
    Drug Des Devel Ther; 2018; 12():575-582. PubMed ID: 29593380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effect on Heptest of low molecular weight heparin fractions and preparations with various anti-IIa and anti-Xa activities.
    Bara L; Mardiguian J; Samama M
    Thromb Res; 1990 Feb; 57(4):585-92. PubMed ID: 2158152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HEPTEST: a suitable method for monitoring heparin during pregnancy.
    Campbell PJ; Tirvengadum MA; Pickering W; Cohen H; Ryan KE
    Clin Lab Haematol; 1999 Jun; 21(3):193-9. PubMed ID: 10448601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of three low-molecular weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteers.
    Eriksson BI; Söderberg K; Widlund L; Wandeli B; Tengborn L; Risberg B
    Thromb Haemost; 1995 Mar; 73(3):398-401. PubMed ID: 7667822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant effects and tissue factor pathway inhibitor after intrapulmonary low-molecular-weight heparin.
    Harenberg J; Malsch R; Angelescu M; Lange C; Michaelis HC; Wolf H; Heene DL
    Blood Coagul Fibrinolysis; 1996 Jun; 7(4):477-83. PubMed ID: 8840001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Pharmacokinetic Profile of 3 Batches of Ovine Low-Molecular-Weight Heparin and 1 Batch of Branded Enoxaparin.
    Jeske W; Kouta A; Duff R; Rangnekar V; Niverthi M; Hoppensteadt D; Fareed J; Yao Y
    Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):150S-156S. PubMed ID: 30198315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Studies on the Anticoagulant Profile of Branded Enoxaparin and a New Biosimilar Version.
    Qneibi D; Ramacciotti E; Macedo AS; Caffaro RA; Agati LB; Siddiqui F; Kouta A; Hoppensteadt D; Fareed J; Carter CA
    Clin Appl Thromb Hemost; 2020; 26():1076029620960820. PubMed ID: 32996340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monitoring of plasma concentration of low molecular weight heparin--comparative evaluation with chromogenic and clotting assays].
    Katagiri H; Itoh S; Uchida T; Kawai Y; Watanabe K
    Rinsho Byori; 1999 Nov; 47(11):1046-51. PubMed ID: 10590682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation a new generation of low molecular weight heparin.
    Zhao D; Sang Q; Cui H
    Biomed Pharmacother; 2016 Apr; 79():194-200. PubMed ID: 27044828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term persistence of biological activity following administration of Enoxaparin sodium (clexane) is due to sequestration of antithrombin-binding low molecular weight fragments--comparison with unfractionated heparin.
    Brieger D; Dawes J
    Thromb Haemost; 1996 May; 75(5):740-6. PubMed ID: 8725716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation.
    Zmuda K; Neofotistos D; Ts'ao CH
    Am J Clin Pathol; 2000 May; 113(5):725-31. PubMed ID: 10800406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin.
    Mousa SA; Linhardt R; Francis JL; Amirkhosravi A
    Thromb Haemost; 2006 Dec; 96(6):816-21. PubMed ID: 17139378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heptest-STAT, a new assay for monitoring of low-molecular-weight heparins, is not influenced by pregnancy-related changes of blood plasma.
    Dempfle CE; Zharkowa U; Elmas E; Ahmad-Nejad P; Neumaier M; Borggrefe M
    Thromb Haemost; 2009 Nov; 102(5):1001-6. PubMed ID: 19888540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.